- Raised $1.5M funding round, Jun 2022
- Raised $1.5M funding round led by OurCrowd, Oct 2020
- Raised $3.8M funding round, Nov 2019
About
Barcode Nanotech is a leading expert in one of the most pressing needs of RNA/DNA therapeutics – precise and safe delivery to target organs and cells. The company develops targeted delivery vehicles for next generation therapeutics. Our proprietary Lipid Nanoparticles (LNPs) enable precise target-site therapeutic activity, while our unique molecular barcoding-platform allows rapid and enhanced delivery optimization. Barcode's delivery vehicles are developed for selective indications such as hard-to-treat-cancers, metabolic diseases, fibrosis and other unmet diseases. The company has signed collaborative agreements with major drug companies for the development of RNA therapeutics. Our Solution: Barcode Nanotech is generating proprietary lipid nanoparticles (LNPs) that are designed to selectively reach target cells and tissues, while protecting the RNA molecules from degradation. Our LNPs are comprised of proprietary ionized lipids and formulations. Our nanoparticles formulations are generated and tested using a unique platform, comprised of the following key elements: (i) An AI-based platform for designing proprietary lipid nanoparticles - for selective delivery of RNA/DNA-therapeutics to target organs and cells (*proprietary ionized lipids + proprietary formulations) (ii) A high-throughput in vivo screening platform that enables rapid simultaneous testing and accurate delivery measurement of tens of particles in a single mouse (iii) LNP optimization platform
Funding history · 5 rounds · $7.6M total
Q&A
- What is Barcode Nanotech's primary focus?
- Barcode Nanotech specializes in developing targeted delivery vehicles, specifically proprietary Lipid Nanoparticles (LNPs), for next-generation RNA/DNA therapeutics, aiming for precise and safe delivery to target organs and cells.
- When was Barcode Nanotech founded?
- Barcode Nanotech was founded in March 2017.
- What is Barcode Nanotech's employee count?
- Barcode Nanotech has 1-10 employees.
- What is the total amount of funding Barcode Nanotech has raised to date?
- Barcode Nanotech has raised a total of $7,600,000 USD.
- Which investors participated in Barcode Nanotech's funding round in June 2022?
- OurCrowd participated in Barcode Nanotech's funding round in June 2022.
- What is the most recent funding event for Barcode Nanotech?
- Barcode Nanotech had a funding round in August 2022, with NGT HealthCare II as an investor.
- What types of diseases does Barcode Nanotech's technology target?
- Barcode Nanotech's delivery vehicles are developed for selective indications such as hard-to-treat cancers, metabolic diseases, and fibrosis.
- What are the key components of Barcode Nanotech's nanoparticle formulation platform?
- Barcode Nanotech's platform includes an AI-based platform for designing proprietary lipid nanoparticles, a high-throughput in vivo screening platform, and an LNP optimization platform.
Team · 3
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | barcode-nano.com/ |
|---|---|
| linkedin.com/company/18052363 |
Identifiers & details
| Former names | Barcode Diagnostics |
|---|---|
| Founded | 2017-3 |
| Employees (exact) | 5 |
Radar intelligence
Patents
| EPO | 3 |
|---|
Web history (Wayback)
| Domain | barcode-nano.com |
|---|
Certificate / subdomain footprint
| Subdomains | 1 |
|---|